Open Journal of Endocrine and Metabolic Diseases
Vol.7 No.4(2017), Paper ID 77984, 15
pages
DOI:10.4236/ojemd.2017.74011
Evaluation of Safety and Efficacy of Glaritus® versus Lantus® in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study
Gaurav Puppalwar, Sandesh Sawant, Bhimsen Silgiri, Kirti Shukla, Hanmant Barkate
Head Medical Affairs-Emerging Markets, Wockhardt Ltd., Mumbai, India
Head-Clinical Operations (India & Emerging Markets), Wockhardt Ltd., Mumbai, India
Head Regulatory Affairs, Wockhardt Ltd, Mumbai, India
Medical Advisor, Medical Affairs, Wockhardt Ltd., Mumbai, India
VP Medical Affairs, Wockhardt Ltd., Mumbai, India
Copyright © 2017 Gaurav Puppalwar, Sandesh Sawant, Bhimsen Silgiri, Kirti Shukla, Hanmant Barkate et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Puppalwar, G. , Sawant, S. , Silgiri, B. , Shukla, K. and Barkate, H. (2017) Evaluation of Safety and Efficacy of Glaritus
® versus Lantus
® in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study.
Open Journal of Endocrine and Metabolic Diseases,
7, 111-125. doi:
10.4236/ojemd.2017.74011.